A polymer electrospinning technology developed by Arsenal Medical (Watertown, MA) improves throughput rates of nanofibers so dramatically that the technology is in play for applications involving drug delivery, very tiny sensors, tissue engineering, filters, and self-healing coatings.
Medical plastics used in the system include polylactic-co-glycolic acid (PLGA) copolymer and other biomaterials such as polyesters.
"We are very excited to unveil this high-throughput slit-surface electrospinning technology, as we believe it represents a major breakthrough in enabling the utilization of core-sheath fibers across a diverse range of applications," says James J. Barry, chief operating officer of Arsenal Medical. "We look forward not only to using this process in our own medical device and therapeutic product development, but also to working with potential collaborators in the nanofiber space, both medical and non-medical."...